Teladoc Health Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
TDOC$8.94-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Other Comprehensive Loss
(in thousands, except share and per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Revenue | $2,602,415 | $2,406,840 | $2,032,707 |
| Expenses: | |||
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 760,031 | 743,987 | 650,258 |
| Operating expenses: | |||
| Advertising and marketing | 688,854 | 623,536 | 416,726 |
| Sales | 213,780 | 227,172 | 250,581 |
| Technology and development | 348,521 | 333,629 | 311,884 |
| General and administrative | 464,659 | 449,855 | 438,007 |
| Acquisition, integration, and transformation costs | 21,110 | 15,620 | 26,643 |
| Restructuring costs | 16,942 | 7,416 | 0 |
| Depreciation | 11,138 | 11,407 | 8,941 |
| Amortization | 325,933 | 244,620 | 195,298 |
| Goodwill impairment | 0 | 13,402,812 | 0 |
| Total expenses | 2,850,968 | 16,060,054 | 2,298,338 |
| Loss from operations | (248,553) | (13,653,214) | (265,631) |
| Loss on extinguishment of debt | 0 | 0 | 43,748 |
| Interest income | (46,782) | (12,674) | (776) |
| Interest expense | 22,282 | 21,944 | 81,141 |
| Other (income) expense, net | (4,445) | 859 | (5,088) |
| Loss before provision for income taxes | (219,608) | (13,663,343) | (384,656) |
| Provision for income taxes | 760 | (3,812) | 44,137 |
| Net loss | (220,368) | (13,659,531) | (428,793) |
| Other comprehensive income (loss), net of tax: | |||
| Currency translation adjustment and other | 5,786 | (36,491) | (24,803) |
| Comprehensive loss | $(214,582) | $(13,696,022) | $(453,596) |
| Net loss per share, basic and diluted | $(1.34) | $(84.60) | $(2.73) |
| Weighted-average shares used to compute basic and diluted net loss per share | 164,578,219 | 161,457,123 | 156,939,349 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.